Revenue (Quarterly) Chart

View Revenue (Quarterly) for PXMBF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
March 31, 2026 9.798M
December 31, 2025 8.974M
September 30, 2025 9.135M
June 30, 2025 7.744M
March 31, 2025 6.289M
December 31, 2024 6.136M
September 30, 2024 6.220M
June 30, 2024 5.932M
March 31, 2024 5.639M
December 31, 2023 5.211M
September 30, 2023 5.664M
June 30, 2023 4.836M
March 31, 2023 4.054M
December 31, 2022 3.799M
September 30, 2022 3.918M
June 30, 2022 3.644M
March 31, 2022 2.992M
December 31, 2021 3.308M
Date Value
September 30, 2021 2.691M
June 30, 2021 2.705M
March 31, 2021 2.482M
December 31, 2020 2.121M
September 30, 2020 1.995M
June 30, 2020 1.838M
March 31, 2020 2.511M
December 31, 2019 2.372M
September 30, 2019 2.394M
June 30, 2019 2.299M
March 31, 2019 1.939M
December 31, 2018 2.039M
September 30, 2018 1.789M
June 30, 2018 1.451M
March 31, 2018 1.353M
December 31, 2017 1.087M
September 30, 2017 1.018M
June 30, 2017 0.8102M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Getinge AB 814.27M
Xvivo Perfusion AB 26.36M
Abbott Laboratories 11.16B
AngioDynamics, Inc. 78.42M
Alphatec Holdings, Inc. 192.11M